Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spire Healthcare GroupCHIX:SPIL -0.46%75 EV-to-EBIT is 17.65 as of Jul. 18, 2026, which is 13% below its 10-year median of 20.26. GuruFocus rates CHIX:SPIL with a GF Score™ of 75/100 and a GF Value™ of £2.72 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 470 Healthcare Providers & Services companies, Spire Healthcare Group ranks worse than 56.38% on this metric.
The historical rank and industry rank for Spire Healthcare Group's EV-to-EBIT or its related term are showing as below:
CHIX:SPIl'
s EV-to-EBIT Range Over the Past 10 Years
Min: -14.23 Med: 20.26 Max: 49.31
Current: 17.65
During the past 13 years, the highest EV-to-EBIT of Spire Healthcare Group was 49.31. The lowest was -14.23. And the median was 20.26.
CHIX:SPIl's EV-to-EBIT is ranked worse than 56.38% of 470
companies
in the Healthcare Providers & Services industry
Industry Median: 15.72
vs CHIX:SPIl: 17.65
Spire Healthcare Group (CHIX:SPIl) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Spire Healthcare Group's Enterprise Value for the quarter that ended in Dec. 2025 was £1,949 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Spire Healthcare Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was £122 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Spire Healthcare Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spire Healthcare Group EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Spire Healthcare Group's EV-to-EBIT falls into.
Spire Healthcare Group's current Enterprise Value is £2,155 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Spire Healthcare Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was £122 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spire Healthcare Group (CHIX:SPIL) has a EV-to-EBIT of 17.65 as of Jul. 18, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Spire Healthcare Group and its competitors. This is 13% below median its historical median of 20.26. According to the industry distribution chart, Spire Healthcare Group ranks #265 out of 470 companies in the Healthcare Providers & Services industry, placing it in the top 56.4%.
Is Spire Healthcare Group's EV-to-EBIT too high?
Spire Healthcare Group's current EV-to-EBIT of 17.65 is 13% below median its 10-year median of 20.26. The Healthcare Providers & Services industry median EV-to-EBIT is 15.72. Spire Healthcare Group's value of 17.65 is 12.3% above this industry median. Based on the distribution chart, Spire Healthcare Group ranks #265 out of 470 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Spire Healthcare Group has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spire Healthcare Group's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Spire Healthcare Group ranks #265 out of 470 companies for EV-to-EBIT. This places Spire Healthcare Group in the lower half of its industry. The industry median EV-to-EBIT is 15.72. Spire Healthcare Group's value of 17.65 is 12.3% above this benchmark. While the company's 10-year median is 20.26 vs. the industry median of 15.72, Spire Healthcare Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.72, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spire Healthcare Group's current EV-to-EBIT of 17.65 is 12.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Spire Healthcare Group and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spire Healthcare Group's current EV-to-EBIT is 17.65, which is 13% below median its own 10-year median of 20.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spire Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, Spire Healthcare Group (CHIX:SPIL) is currently considered Modestly Undervalued. The stock's GF Value™ is £2.72, compared to a current price of £2.19 — trading 19.7% below its estimated fair value. The current EV-to-EBIT is 17.65, which is 13% below median its 10-year median of 20.26 and 12.3% above the Healthcare Providers & Services industry median of 15.72. Spire Healthcare Group's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Spire Healthcare Group (CHIX:SPIL), the current EV-to-EBIT is 17.65 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spire Healthcare Group (CHIX:SPIL) Overvalued in 2026?
Based on GuruFocus' analysis, Spire Healthcare Group stock appears to be undervalued.
The current stock price of £2.19 is trading 19.7% below its estimated GF Value™ of £2.72.
GuruFocus considers Spire Healthcare Group to be Modestly Undervalued.
Key valuation signals for CHIX:SPIL:
EV-to-EBIT: 17.65 (13% below median its 10-year median of 20.26)
GF Value™: £2.72 vs. price of £2.19 (19.7% below fair value)
Industry Position: 12.3% above the Healthcare Providers & Services median (#265 of 470)
No single metric tells the full story. See the CHIX:SPIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The company has two operating segments: the hospitals business and the Primary care. The company generates the majority of its revenue from Hospital Business, which consists of hospitals, clinics, medical centres and consulting rooms. The company provide diagnostics, inpatient, day case and outpatient care in areas including orthopaedics, gynaecology, cardiology, neurology, oncology and general surgery. The primary care segment encompasses services focused on the primary care needs of outpatients, including GP services, occupational health services or mental and physical health services.
75GF Score
Get the complete analysis for CHIX:SPIL
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SPIL has been successfully added to your 
